Publicador de continguts



Building Scalable Pathogen Genomic Epidemiology in Ethiopia

Cadena d'ADN
Foto: Canva
01/06/2023 - 01/06/2027
Amsterdam Institute for Global Health and Development (AIGHD)

The 21st century is witnessing an increased incidence of epidemics (Zika, Dengue, Ebola, SARS), with the recent COVID-19 being the latest highlight. Following the outbreak of several infectious diseases in the last decade, the need to generate real-time pathogen genomic data for public health interventions has become more important than ever.

In the African context, infrastructure, human resource capacity, data analysis including bioinformatics, lack of linkage between clinical, epidemiological and pathogen genomic data and interaction between clinicians, researchers and decision makers are some of the major challenges.


The EpiGen project aims to build capacity for integrated pathogen genomic surveillance for informed public health decision-making.

The overarching specific objectives include strengthening the collection and analysis of clinical and epidemiological data; enhancing the capacity and capability for pathogen genomic sequencing, including strengthening laboratory infrastructure, human resources, pathogen genomic data analysis and integration of metadata with genomic data; developing and implementing innovative digital diagnostic platforms; creating semi-real-time mobile phone applications for policy making; and promoting communities of practice and knowledge exchange by fostering African collaboration and networking in the field of pathogen genomic surveillance for infectious diseases.

The Consortium

The multidisciplinary consortium of the EpiGen project consists of several Ethiopian institutions involved in national public health programmes and EU partners (Netherlands, Spain and Germany).

Overall, the model approach proposed by EpiGen will strengthen Ethiopia's national efforts to reduce the threat of infectious diseases. The implementation of national genomics-informed surveillance for infectious diseases will play an important public health role in contributing to disease prevention and control programmes in Ethiopia and beyond.

Total Funding

5,500,000 € (EDCTP3)

Our Team

ISGlobal Staff Involved

Altres projectes

Veure projectes passats


Combatent la Resistència Bacteriana a Europa


Development of Novel Gastrointestinal Biomarkers for Use in HIV Incidence Determination in a Sub-Saharan African Setting


Combatting Bacterial Resistance in Europe - Carbapenem Resistance


Improving Maternal and Infant Health by reducing malaria risks in African women: evaluation of the safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women


Integrating and decentralizing diabetes and hypertension services in Africa


Improving Care through Azithromycin Research for Infants in Africa


Predicting the Future: Incipient Tuberculosis


Large Clinical Trial in Africa on the Treatment of Mild Cases of COVID-19


Evaluating a new stool based qPCR for diagnosis of tuberculosis in children and people living with HIV

Hepatitis C Free Baleares

Eliminating hepatitis C on the Balearic Islands (Mallorca, Menorca and Ibiza): a study in governmental and non-governmental addiction service centres, a mobile methadone unit and a prison to test and link people who use drugs to HCV care.


Reconnecting Transmission to Global Tuberculosis Control by Mapping Pathogen Transmission Events to Host Infection Status


Quantifiable stool-based TB PCR to Improve Diagnostics and Treatment Monitoring


ENDing COVID-19 Variants Of concern through Cohort studies (END-VOC)


Digital Twins Enabled Indoor Air Quality Management for Healthy Living


Viral Hepatitis COMmunity Screening, Vaccination, and Care


Community knowledge generation through scientific culture, urban ecology and art


L'Aliança Científica per a l'Eradicació de la Malària (MESA) té com a objectiu avançar en la ciència de l'eradicació de la malària.


Noves Eines per al Diagnòstic i l'Avaluació del Pacient amb Malaltia de Chagas

RTS,S Vaccine Immunology Study

Study of immune correlates of protection against malaria after vaccination with RTS,S/AS01E: a comprehensive immunological arm of a Phase III double-blind, randomized, controlled multi-center trial

Control of Leishmaniasis. From bench to bedside and community


Grup de recerca en patología importada i malaties emergents i re-emergents


Nuevos regímenes de quimioterapia y biomarcadores para la enfermedad de Chagas


Broad One Health Endectocide-based Malaria Intervention in Africa


Unravelling Disease Tolerance and Host Resistance in Afebrile 'P. falciparum' Infections: a Prospective Study in Mozambican Adults


P. falciparum genomic intelligence in Mozambique


Administración masiva y focal de fármacos antimaláricos para avanzar hacia la eliminación de la malaria en Mozambique: acelerando la implementación de programas y políticas


MULTIple doses of IPTi Proposal: a Lifesaving high Yield intervention


Citizens engagement digital platform for collective intelligence in pandemics


Novel organ-on-a-chip technology to study extracellular vesicles-mediated cryptic infections in Plasmodium vivax malaria

MENA Migrant Health

Transforming data collection and surveillance to drive migrant health research, care and policy


Social affairs and sex in P. falciparum: implications for malaria elimination


Portable Graphene Multiplex Electrochemical Sensor for Rapid Detection of Severe Malaria


Identifying Severe Malaria with a new Aptamer-based Rapid diagnostic Test